sorry I'm not well versed in how pharma acquisitions play out. can someone explain the potential pros and cons for proceeding to stage 3 trials self funded ($50m US cost), and partnering.
what does the share price do in both scenarios. not looking for price predictions, more timelines and potential cost differential as a round numbered multiplier based on success
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.006(10.5%) |
Mkt cap ! $82.87M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.0¢ | $5.366M | 117.3M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2064980 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 211662 | 3 |
View Market Depth
| Last trade - 13.35pm 19/06/2025 (20 minute delay) ? |
| SNT (ASX) Chart |